Category: Diagnostic Technologies

Diagnostic Technologies

ViewsML Raises $4.9 Million for AI-Based Virtual Tissue Staining

The seed funding will support the commercialization of a platform designed to generate biomarker insights from pathology images without laboratory staining.

Seegene Introduces New Data Platform and Automated PCR System
Genome Detective Unveils Automated Pathogen Genomics Platform
QuidelOrtho Completes Acquisition of LEX Diagnostics and Molecular Testing Platform
Caris Life Sciences AI Algorithm Flags Potential Cancer Misdiagnoses in Lung Cancer Study
Clarapath Releases Updated Robotic Microtomy Platform for Clinical Histology Labs
Biocartis Earns European Certification for Colorectal Cancer Companion Diagnostic Test
CellCarta Secures Exclusive Global Rights to Deploy Aspyre Lung Assay in Lung Cancer Clinical Trials
Biotium’s New Cell Barcoding Kit Allows Up to 15-Sample Multiplexing in a Single Flow Cytometry Tube
Seed Funding to Advance Biopsy Catchment Technology and Liquid Specimen Biorepository

Diagnostic Technologies

Clinical Trial to Evaluate Finger-Prick Blood Test for Alzheimer’s Diagnosis

The study will analyze three key proteins to determine if blood-based biomarkers can provide an earlier and more accessible diagnostic method.

Diagnostic Technologies

Autonomous Robotic Phlebotomy Shows High Success Rates in Multicenter Trial

A multicenter trial published in Clinical Chemistry reports Vitestro’s autonomous phlebotomy system achieved a 94.5% first-stick success rate, with low hemolysis and adverse event rates, in routine clinical settings.

Anatomic Pathology

AI Platform Predicts Biomarker Expression from Standard Pathology Slides, With No Additional Staining Required

ViewsML will present an AI platform at USCAP 2026 that predicts biomarker expression from standard H&E slides, enabling per-cell spatial analysis without additional staining, according to the company.

Digital Pathology

PathAI and MedStar Health Partner to Deploy Digital Pathology Platform

The multi-year collaboration includes the deployment of the AISight Dx platform and AI algorithms across the health system’s laboratory network.

Clinical Chemistry

Alternative Blood Test More Effective for Guiding Heart Disease Treatment

Research indicates that apolipoprotein B testing outperforms standard LDL cholesterol tests in predicting risk and guiding therapy.

Flow Cytometry

Sales for CyPath Noninvasive Lung Cancer Diagnostic Increase 146% in First Quarter

Increased adoption of flow cytometry and artificial intelligence tools helps clinicians manage the rising number of indeterminate pulmonary nodules.

Hematology & Serology

Automated Cytomegalovirus PCR Assay Receives IVDR Certification for Transplant Care

The test allows for simultaneous detection of multiple viruses on a sample-to-answer platform designed for immunocompromised patients.

Immunoassay

Maternal Blood Test Identifies Autoantibodies Linked to Autism Subtype

The diagnostic tool identifies a specific biological cause of autism with more than 97% predictive accuracy.

Mass Spectrometry

Thermo Fisher Scientific and PRECISE Partner on Singapore Proteomics Study

The collaboration will use multi-omic platforms and AI-driven analytics to identify disease patterns and improve patient stratification within the PRECISE-SG100K study.

Microbiology

Breath Test Using Carbon Isotopes May Quickly Confirm Bacterial Infections

A proof-of-concept study shows that bacteria-metabolized molecules enriched with carbon-13 produce detectable exhaled CO2, enabling rapid infection identification with inexpensive infrared scanners.

Molecular Diagnostics

FDA Issues Draft Guidance for Gene Therapy Genome Editing Safety

The recommendations focus on using next-generation sequencing to evaluate off-target editing risks and chromosomal integrity.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

Rapid Urine Test Identifies Effective UTI Antibiotics in Under Six Hours

A rapid urine test identified effective UTI antibiotics in an average of 5.85 hours, matching standard lab accuracy in a University of Reading study published in the Journal of Antimicrobial Chemotherapy.